The CYP17 MspA1 polymorphism is not associated with an increased risk of uterine leiomyomas in a Japanese population.

The CYP17 gene is thought to be a candidate gene for susceptibility to hormone-related diseases. A single (T?C) nucleotide polymorphism in the promoter region of CYP17 is speculated to influence its transcription. The present study was conducted to investigate the possible association between uterin...

Full description

Bibliographic Details
Main Authors: Tsujino, T, Ohara, N, Yoshida, S, Kennedy, S, Takemura, N, Deguchi, M, Maruo, T
Format: Journal article
Language:English
Published: 2006
_version_ 1797086270671814656
author Tsujino, T
Ohara, N
Yoshida, S
Kennedy, S
Takemura, N
Deguchi, M
Maruo, T
author_facet Tsujino, T
Ohara, N
Yoshida, S
Kennedy, S
Takemura, N
Deguchi, M
Maruo, T
author_sort Tsujino, T
collection OXFORD
description The CYP17 gene is thought to be a candidate gene for susceptibility to hormone-related diseases. A single (T?C) nucleotide polymorphism in the promoter region of CYP17 is speculated to influence its transcription. The present study was conducted to investigate the possible association between uterine leiomyomas and CYP17 gene polymorphism in a Japanese population. Genotyping analysis of the CYP17 gene was performed in 138 leiomyoma cases, 183 unaffected controls and 179 population controls using polymerase chain reaction and restriction fragment length polymorphism analysis. No significant difference in CYP17 genotype distribution was noted between leiomyoma cases and controls. Women carrying the A2 allele were not at an increased risk of uterine leiomyoma compared with those carrying the A1 allele in unaffected controls (odds ratio, 1.26; 95% confidence interval, 0.92-1.72) and those carrying the A1 allele in population controls (odds ratio, 0.99; 95% confidence interval, 0.72-1.36). No significant difference in allele frequencies were found between leiomyoma cases and controls. These findings suggest that CYP17 gene polymorphism is unlikely to be associated with an increased risk of uterine leiomyomas in a Japanese population.
first_indexed 2024-03-07T02:19:44Z
format Journal article
id oxford-uuid:a37f7f9c-a3eb-4b4d-ba9b-1a44b114ea0c
institution University of Oxford
language English
last_indexed 2024-03-07T02:19:44Z
publishDate 2006
record_format dspace
spelling oxford-uuid:a37f7f9c-a3eb-4b4d-ba9b-1a44b114ea0c2022-03-27T02:27:24ZThe CYP17 MspA1 polymorphism is not associated with an increased risk of uterine leiomyomas in a Japanese population.Journal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:a37f7f9c-a3eb-4b4d-ba9b-1a44b114ea0cEnglishSymplectic Elements at Oxford2006Tsujino, TOhara, NYoshida, SKennedy, STakemura, NDeguchi, MMaruo, TThe CYP17 gene is thought to be a candidate gene for susceptibility to hormone-related diseases. A single (T?C) nucleotide polymorphism in the promoter region of CYP17 is speculated to influence its transcription. The present study was conducted to investigate the possible association between uterine leiomyomas and CYP17 gene polymorphism in a Japanese population. Genotyping analysis of the CYP17 gene was performed in 138 leiomyoma cases, 183 unaffected controls and 179 population controls using polymerase chain reaction and restriction fragment length polymorphism analysis. No significant difference in CYP17 genotype distribution was noted between leiomyoma cases and controls. Women carrying the A2 allele were not at an increased risk of uterine leiomyoma compared with those carrying the A1 allele in unaffected controls (odds ratio, 1.26; 95% confidence interval, 0.92-1.72) and those carrying the A1 allele in population controls (odds ratio, 0.99; 95% confidence interval, 0.72-1.36). No significant difference in allele frequencies were found between leiomyoma cases and controls. These findings suggest that CYP17 gene polymorphism is unlikely to be associated with an increased risk of uterine leiomyomas in a Japanese population.
spellingShingle Tsujino, T
Ohara, N
Yoshida, S
Kennedy, S
Takemura, N
Deguchi, M
Maruo, T
The CYP17 MspA1 polymorphism is not associated with an increased risk of uterine leiomyomas in a Japanese population.
title The CYP17 MspA1 polymorphism is not associated with an increased risk of uterine leiomyomas in a Japanese population.
title_full The CYP17 MspA1 polymorphism is not associated with an increased risk of uterine leiomyomas in a Japanese population.
title_fullStr The CYP17 MspA1 polymorphism is not associated with an increased risk of uterine leiomyomas in a Japanese population.
title_full_unstemmed The CYP17 MspA1 polymorphism is not associated with an increased risk of uterine leiomyomas in a Japanese population.
title_short The CYP17 MspA1 polymorphism is not associated with an increased risk of uterine leiomyomas in a Japanese population.
title_sort cyp17 mspa1 polymorphism is not associated with an increased risk of uterine leiomyomas in a japanese population
work_keys_str_mv AT tsujinot thecyp17mspa1polymorphismisnotassociatedwithanincreasedriskofuterineleiomyomasinajapanesepopulation
AT oharan thecyp17mspa1polymorphismisnotassociatedwithanincreasedriskofuterineleiomyomasinajapanesepopulation
AT yoshidas thecyp17mspa1polymorphismisnotassociatedwithanincreasedriskofuterineleiomyomasinajapanesepopulation
AT kennedys thecyp17mspa1polymorphismisnotassociatedwithanincreasedriskofuterineleiomyomasinajapanesepopulation
AT takemuran thecyp17mspa1polymorphismisnotassociatedwithanincreasedriskofuterineleiomyomasinajapanesepopulation
AT deguchim thecyp17mspa1polymorphismisnotassociatedwithanincreasedriskofuterineleiomyomasinajapanesepopulation
AT maruot thecyp17mspa1polymorphismisnotassociatedwithanincreasedriskofuterineleiomyomasinajapanesepopulation
AT tsujinot cyp17mspa1polymorphismisnotassociatedwithanincreasedriskofuterineleiomyomasinajapanesepopulation
AT oharan cyp17mspa1polymorphismisnotassociatedwithanincreasedriskofuterineleiomyomasinajapanesepopulation
AT yoshidas cyp17mspa1polymorphismisnotassociatedwithanincreasedriskofuterineleiomyomasinajapanesepopulation
AT kennedys cyp17mspa1polymorphismisnotassociatedwithanincreasedriskofuterineleiomyomasinajapanesepopulation
AT takemuran cyp17mspa1polymorphismisnotassociatedwithanincreasedriskofuterineleiomyomasinajapanesepopulation
AT deguchim cyp17mspa1polymorphismisnotassociatedwithanincreasedriskofuterineleiomyomasinajapanesepopulation
AT maruot cyp17mspa1polymorphismisnotassociatedwithanincreasedriskofuterineleiomyomasinajapanesepopulation